Search > Depression
My employer runs this trial

Augmented Depression Therapy for Depression

JF
Overseen ByJay Fournier, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ohio State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This research study plans to examine the use of Augmented Depression Therapy (ADepT) in order to evaluate what patients think about ADepT and how well it works. ADepT is a type of therapy that builds wellbeing and is being provided to you as standard of care.

ADepT treatment consists of 15 therapy sessions (typically provided weekly) with each session lasting around 60 minutes. Following these sessions, you can receive five optional booster sessions over the next 12 months with each of these lasting around 60 minutes. Ultimately, the timing and duration of these sessions will be determined between you and your provider and scheduled accordingly.

As part of this study you will be randomized (randomly assigned) to different research assessment lengths before the start of treatment and then will complete assessments for the 12 months following the end of the weekly portion of ADepT treatment. The length of your participation will be between 70 weeks to 82 weeks.

Are You a Good Fit for This Trial?

This trial is for adults diagnosed with depression or major depressive disorder who are interested in trying a new type of talk therapy. Specific inclusion and exclusion criteria are not listed, but participants should be able to attend regular therapy sessions over about a year.

Inclusion Criteria

Scoring > 10 on the PHQ-9
Have sufficient knowledge of written and spoken English to provide consent and utilize therapy resources and take assessment measures throughout the protocol without the assistance of a translator
I am between 18 and 65 years old.
See 1 more

Exclusion Criteria

History of learning disabilities or organic brain change (e.g., from injury or from neurological disorders)
Current marked risk to self (self-harm or suicidal ideation) that cannot be managed safely within the ADepT treatment frame
I have been diagnosed with a psychotic or bipolar disorder.
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • Augmented Depression Therapy (ADepT)

Trial Overview

The study is testing Augmented Depression Therapy (ADepT), which involves up to 15 weekly one-hour sessions plus optional booster sessions over the next year. Participants will also complete assessments before and after treatment.

How Is the Trial Designed?

6

Treatment groups

Experimental Treatment

Group I: 8 week baseline + ADepTExperimental Treatment1 Intervention
Group II: 7 week baseline + ADepTExperimental Treatment1 Intervention
Group III: 6 week baseline + ADepTExperimental Treatment1 Intervention
Group IV: 5 week baseline + ADepTExperimental Treatment1 Intervention
Group V: 4 week baseline + ADepTExperimental Treatment1 Intervention
Group VI: 3 week baseline + ADepTExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials
891
Recruited
2,659,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.